Bullous Pemphigoid Market is driven by Geriatric Population Growth
The Bullous Pemphigoid market comprises therapeutic products designed to treat a chronic autoimmune skin disorder characterized by subepidermal blistering. Key product categories include corticosteroids, immunosuppressants, monoclonal antibodies, and emerging biologics. Corticosteroid formulations, widely used as first-line therapy, offer rapid symptom relief but may pose long-term safety...
0 Comments 0 Shares 105 Views 0 Reviews